Market Closed -
OTC Markets
12:41:28 2024-04-16 pm EDT
|
5-day change
|
1st Jan Change
|
640
USD
|
+2.40%
|
|
0.00%
|
-55.23%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
2,348
|
445.4
|
407.7
|
353.2
|
271.7
|
58.28
|
Enterprise Value (EV)
1 |
2,917
|
1,046
|
1,165
|
1,151
|
1,125
|
1,049
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.06
x
|
0.2
x
|
0.19
x
|
0.18
x
|
0.12
x
|
0.03
x
|
EV / Revenue
|
1.32
x
|
0.46
x
|
0.55
x
|
0.59
x
|
0.51
x
|
0.48
x
|
EV / EBITDA
|
12.4
x
|
3.99
x
|
7.28
x
|
10.3
x
|
8.72
x
|
27.6
x
|
EV / FCF
|
12.2
x
|
-3.73
x
|
-17.7
x
|
171
x
|
25.6
x
|
-6.49
x
|
FCF Yield
|
8.18%
|
-26.8%
|
-5.66%
|
0.59%
|
3.9%
|
-15.4%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
0.78
|
0.78
|
0.78
|
0.78
|
0.78
|
0.79
|
Reference price
2 |
3,030,137
|
573,973
|
524,658
|
453,425
|
347,945
|
73,959
|
Announcement Date
|
2/23/18
|
2/20/19
|
3/12/20
|
2/26/21
|
2/22/22
|
2/21/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
2,209
|
2,265
|
2,130
|
1,938
|
2,212
|
2,173
|
EBITDA
1 |
236
|
262
|
160
|
112
|
129
|
38
|
EBIT
1 |
109
|
130
|
50
|
-2
|
10
|
-69
|
Operating Margin
|
4.93%
|
5.74%
|
2.35%
|
-0.1%
|
0.45%
|
-3.18%
|
Earnings before Tax (EBT)
1 |
186
|
-165
|
-20
|
-93
|
-105
|
-118
|
Net income
1 |
134
|
-163
|
-175
|
-112
|
-77
|
-188
|
Net margin
|
6.07%
|
-7.2%
|
-8.22%
|
-5.78%
|
-3.48%
|
-8.65%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
238.6
|
-280.9
|
-65.88
|
6.75
|
43.88
|
-161.6
|
FCF margin
|
10.8%
|
-12.4%
|
-3.09%
|
0.35%
|
1.98%
|
-7.44%
|
FCF Conversion (EBITDA)
|
101.11%
|
-
|
-
|
6.03%
|
34.01%
|
-
|
FCF Conversion (Net income)
|
178.08%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/18
|
2/20/19
|
3/12/20
|
2/26/21
|
2/22/22
|
2/21/23
|
Fiscal Period: December |
2020 Q4
|
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
---|
Net sales
1 |
476
|
553
|
567
|
557
|
535
|
659
|
642
|
506
|
366
|
438
|
EBITDA
1 |
25
|
49
|
43
|
48
|
40
|
57
|
61
|
-8
|
-57
|
-83
|
EBIT
1 |
-4
|
18
|
14
|
19
|
10
|
26
|
35
|
-35
|
-80
|
-139
|
Operating Margin
|
-0.84%
|
3.25%
|
2.47%
|
3.41%
|
1.87%
|
3.95%
|
5.45%
|
-6.92%
|
-21.86%
|
-31.74%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-58
|
-21
|
-23
|
-47
|
14
|
-3
|
93
|
-50
|
-228
|
-170
|
Net margin
|
-12.18%
|
-3.8%
|
-4.06%
|
-8.44%
|
2.62%
|
-0.46%
|
14.49%
|
-9.88%
|
-62.3%
|
-38.81%
|
EPS
2 |
-73,973
|
-27,397
|
-28,767
|
-60,274
|
17,808
|
-4,110
|
117,808
|
-63,014
|
-289,041
|
-215,068
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/21
|
5/6/21
|
8/3/21
|
11/3/21
|
2/22/22
|
5/4/22
|
7/26/22
|
11/14/22
|
2/21/23
|
5/18/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
569
|
601
|
757
|
798
|
853
|
991
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.411
x
|
2.294
x
|
4.731
x
|
7.125
x
|
6.612
x
|
26.08
x
|
Free Cash Flow
1 |
239
|
-281
|
-65.9
|
6.75
|
43.9
|
-162
|
ROE (net income / shareholders' equity)
|
21.2%
|
-16%
|
-22.3%
|
-16.2%
|
-12.4%
|
-41.2%
|
ROA (Net income/ Total Assets)
|
2.47%
|
3.05%
|
1.32%
|
-0.05%
|
0.26%
|
-1.95%
|
Assets
1 |
5,417
|
-5,348
|
-13,301
|
207,407
|
-29,090
|
9,663
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
197
|
326
|
152
|
69
|
73
|
69
|
Capex / Sales
|
8.92%
|
14.39%
|
7.14%
|
3.56%
|
3.3%
|
3.18%
|
Announcement Date
|
2/23/18
|
2/20/19
|
3/12/20
|
2/26/21
|
2/22/22
|
2/21/23
|
|
1st Jan change
|
Capi.
|
---|
| -55.23% | 503M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|